Helen A Vlachos
Overview
Explore the profile of Helen A Vlachos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
255
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ikeno F, Brooks M, Nakagawa K, Kim M, Kaneda H, Mitsutake Y, et al.
J Am Coll Cardiol
. 2017 Jan;
69(4):395-403.
PMID: 28126156
Background: The extent of coronary disease affects clinical outcomes and may predict the effectiveness of coronary revascularization with either coronary artery bypass graft (CABG) surgery or percutaneous coronary intervention (PCI)....
2.
Epps K, Holper E, Selzer F, Vlachos H, Gualano S, Abbott J, et al.
Circ Cardiovasc Qual Outcomes
. 2016 Feb;
9(2 Suppl 1):S16-25.
PMID: 26908855
Background: Women <50 years of age with coronary artery disease may represent a group at higher risk for recurrent ischemic events after percutaneous coronary intervention (PCI); however, no long-term, multicenter...
3.
Mulukutla S, Marroquin O, Vlachos H, Selzer F, Toma C, Kip K, et al.
Am J Cardiol
. 2012 Dec;
111(4):486-92.
PMID: 23211356
The optimal duration of dual-antiplatelet therapy (DAPT) after drug-eluting stent (DES) implantation is an important, unanswered question. This study was designed to evaluate the association of varying durations of DAPT...
4.
Leitner J, Vlachos H, Selzer F, Jamal S, Kip K, Williams D, et al.
Am J Cardiol
. 2011 Nov;
109(4):466-70.
PMID: 22118825
Percutaneous coronary intervention (PCI) for protected left main coronary artery (PLM) disease is complex because of patient and lesion factors; however, limited data exist on the outcomes of drug-eluting stent...
5.
Baldwin D, Abbott J, Trost J, Vlachos H, Selzer F, Glaser R, et al.
Am J Cardiol
. 2010 Sep;
106(7):946-51.
PMID: 20854955
The effectiveness and safety of drug-eluting stents (DES) compared with bare-metal stents (BMS) in saphenous vein graft (SVG) disease remains unclear. In particular, there is a paucity of data on...
6.
Bangalore S, Vlachos H, Selzer F, Wilensky R, Kip K, Williams D, et al.
Catheter Cardiovasc Interv
. 2010 May;
77(1):22-8.
PMID: 20506328
Objectives: To evaluate the efficacy and safety of drug eluting stents (DES) when compared with bare metal stents (BMS) in patients with moderate to severe calcified coronary lesions. Background: Calcified...
7.
Wolf W, Vlachos H, Marroquin O, Lee J, Smith C, Anderson W, et al.
Circ Cardiovasc Interv
. 2010 Feb;
3(1):42-9.
PMID: 20118153
Background: Diabetes is a powerful predictor of adverse events in patients undergoing percutaneous coronary intervention. Drug-eluting stents reduce restenosis rates compared with bare metal stents; however, controversy remains regarding which...
8.
Mulukutla S, Vlachos H, Marroquin O, Selzer F, Holper E, Abbott J, et al.
JACC Cardiovasc Interv
. 2009 Feb;
1(2):139-47.
PMID: 19212456
Objectives: This study sought to evaluate the safety and efficacy of drug-eluting stents (DES) compared with bare-metal stents (BMS) in patients with insulin- and noninsulin-treated diabetes. Background: Diabetes is a...
9.
Marroquin O, Selzer F, Mulukutla S, Williams D, Vlachos H, Wilensky R, et al.
N Engl J Med
. 2008 Jan;
358(4):342-52.
PMID: 18216354
Background: Recent reports suggest that off-label use of drug-eluting stents is associated with an increased incidence of adverse events. Whether the use of bare-metal stents would yield different results is...
10.
Abbott J, Voss M, Nakamura M, Cohen H, Selzer F, Kip K, et al.
J Am Coll Cardiol
. 2007 Nov;
50(21):2029-36.
PMID: 18021868
Objectives: We investigated the effectiveness and safety of drug-eluting stents (DES) as used in routine clinical practice. Background: Randomized trials have shown that DES prevent target vessel revascularization in selected...